Tempest Therapeutics, Inc. Earnings Per Share (Basic)
Tempest Therapeutics, Inc. (TPST) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Tempest Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- Tempest Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$2.53.
- Tempest Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.79.
- Tempest Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$2.07.
- Tempest Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$6.33.
- Tempest Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$19.50.
- Tempest Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.91.
- Tempest Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$3.09.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-13 | -$2.52 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$2.53 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$6.33 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | -$0.79 10-Q · filed 2025-11-05 | -$5.71 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | -$2.07 10-Q · filed 2026-08-13 | -$5.17 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$3.16 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$19.50 10-K · filed 2026-03-30 | -$1.50 10-K · filed 2025-03-27 | ||||||
| 2024-09-30 | -$5.32 10-Q · filed 2025-11-05 | -$0.41 10-Q · filed 2024-11-12 | -$15.48 10-Q · filed 2025-11-05 | -$1.19 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | -$5.52 10-Q · filed 2025-08-11 | -$0.42 10-Q · filed 2024-08-08 | -$10.15 10-Q · filed 2025-08-11 | -$0.78 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | -$4.62 10-Q · filed 2025-05-13 | -$0.36 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | -$1.91 10-K · filed 2025-03-27 | |||||||
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-12 | -$1.57 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.54 10-Q · filed 2024-08-08 | -$1.09 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | -$0.55 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$3.09 10-K · filed 2024-03-19 | |||||||
| 2022-09-30 | -$0.66 10-Q · filed 2023-11-08 | -$2.46 10-Q · filed 2023-11-08 | ||||||
| 2022-06-30 | -$0.79 10-Q · filed 2023-08-10 | -$1.88 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$1.18 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | -$7.47 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | -$1.21 10-Q · filed 2022-11-08 | -$7.49 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | -$7.63 10-Q · filed 2022-08-15 | -$17.30 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$10.55 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | -$41.03 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |